Celltrion
068270.KS
#933
Rank
HK$208.30 B
Marketcap
HK$908.31
Share price
3.15%
Change (1 day)
-2.20%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): HK$14.75

According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$14.85. an increase over its 2024 EPS that were of HK$9.66.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025HK$25.46163.66%
2024HK$9.66-53.73%
2023HK$20.87-2.08%
2022HK$21.31-11.72%
2021HK$24.142.03%
2020HK$23.6682.8%
2019HK$12.9418.31%
2018HK$10.94-36.33%
2017HK$17.18161.25%
2016HK$6.582.86%
2015HK$6.4017.84%
2014HK$5.435.87%
2013HK$5.13-70.85%
2012HK$17.58134.09%
2011HK$7.5143.59%
2010HK$5.2374.49%
2009HK$3.00317.8%
2008HK$0.72-71.7%
2007HK$2.54